Dr. Czarnecki earned his MD degree from the University of Freiburg Medical School in Germany. During his residency in Internal Medicine and Critical Care Medicine fellowship at the Mayo Clinic (Rochester, MN), he worked in the lab of Peter Harris, studying the genetics of ciliopathies and Polycystic Kidney Disease (PKD). He completed his fellowship in Nephrology at the Beth Israel Deaconess Medical Center (Boston), investigating mechanisms of signal transduction in primary cilia in the lab of Jagesh Shah. As a junior faculty member at the Brigham and Women’s Hospital Division of Renal Medicine, he launched a subspecialty clinic for Kidney Genetics and PKD. He joined the faculty at the Beth Israel Deaconess Medical Center Division of Nephrology in 2022 and started a new PKD/Genetic Nephrology clinic and research lab.

Dr. Czarnecki specializes in evaluation and expert opinion on genetic kidney disease. His clinic was accredited as the “Center of Excellence for PKD care” by the PKD Foundation. His research focuses on the discovery of novel signaling mechanisms in the pathogenesis